Hans van Houte
Director of Finance/CFO bij NURIX THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Hans van Houte
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 01-03-2016 | - |
Loopbaan van Hans van Houte
Eerdere bekende functies van Hans van Houte
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | 01-01-2011 | - |
| Bionation LLC | Corporate Officer/Principal | - | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - | - |
| Treasurer | - | - |
Opleiding van Hans van Houte
| Babson College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
| Bionation LLC |
- Beurs
- Insiders
- Hans van Houte
- Ervaring
